当前位置:首页 - 行情中心 - 正海生物(300653) - 财务分析 - 利润表

正海生物

(300653)

46.31

-0.38  (-0.81%)

今开:46.22最高:46.72成交:0.22万手 市盈:0.00 上证指数:2586.51   0.26%2019-01-23
昨收:46.69 最低:46.07 换手:0.00%振幅:0.00 深证指数:7536.78  0.27%10:52:51

集合

竞价

利润表

按照会计年度查询:
报告期2018-09-302018-06-302018-03-312017-12-31
一、营业总收入165,469,711.4105,197,363.7447,179,561.64182,782,114.4
营业收入165,469,711.4105,197,363.7447,179,561.64182,782,114.4
二、营业总成本99,075,164.5665,257,240.9425,428,114.29123,117,332.11
营业成本11,863,591.717,951,246.923,442,338.4311,561,961.82
营业税金及附加1,548,250.95944,603.86422,722.991,346,747.84
销售费用61,535,020.0539,812,235.2215,591,137.8776,303,290.96
管理费用12,190,037.0616,572,344.176,234,017.4835,893,892.38
财务费用-791,065.34-450,578.97-230,441.67-2,128,496.78
资产减值损失515,922.79427,389.74-31,660.81139,935.89
三、其他经营收益--------
允许价值变动净收益--------
投资净收益9,282,776.396,470,463.783,666,202.726,199,926.79
联营、合营企业投资收益--------
汇兑净收益--------
四、营业利润76,990,393.7947,239,636.2425,900,215.0970,604,772.84
营业外收入187,521.8254,3304,2001,447,270
营业外支出157,663.76122,203.285,061.9965,193.21
非流动资产处置净损失--------
五、利润总额77,020,251.8547,171,763.0425,819,353.171,986,849.63
所得税11,867,910.47,194,498.133,936,430.3810,317,295.52
未确认的投资损失--------
六、净利润(百万元)65.1539.9821.8861.67
少数股东损益--------
归属于母公司股东的净利润65,152,341.4539,977,264.9121,882,922.7261,669,554.11
七、每股收益0.810.50.270.86
基本每股收益0.810.50.270.86
稀释每股收益0.810.50.270.86
TOP↑